Correlation Between Sunshine Biopharma and Pacira BioSciences,

Can any of the company-specific risk be diversified away by investing in both Sunshine Biopharma and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sunshine Biopharma and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sunshine Biopharma and Pacira BioSciences,, you can compare the effects of market volatilities on Sunshine Biopharma and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sunshine Biopharma with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sunshine Biopharma and Pacira BioSciences,.

Diversification Opportunities for Sunshine Biopharma and Pacira BioSciences,

0.25

Correlation Coefficient

Sunshine Biopharma  Pacira BioSciences,

Modest diversification

The 3 months correlation between Sunshine and Pacira is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Sunshine Biopharma and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Sunshine Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sunshine Biopharma are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Sunshine Biopharma i.e., Sunshine Biopharma and Pacira BioSciences, go up and down completely randomly.

Pair Corralation between Sunshine Biopharma and Pacira BioSciences,

Given the investment horizon of 90 days Sunshine Biopharma is expected to generate 5.15 times less return on investment than Pacira BioSciences,. In addition to that, Sunshine Biopharma is 1.86 times more volatile than Pacira BioSciences,. It trades about 0.01 of its total potential returns per unit of risk. Pacira BioSciences, is currently generating about 0.14 per unit of volatility. If you would invest  1,733  in Pacira BioSciences, on October 20, 2024 and sell it today you would earn a total of  503.00  from holding Pacira BioSciences, or generate 29.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sunshine Biopharma  vs.  Pacira BioSciences,

Sunshine Biopharma

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sunshine Biopharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, Sunshine Biopharma is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pacira BioSciences,

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sunshine Biopharma and Pacira BioSciences,

The main advantage of trading using opposite Sunshine Biopharma and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sunshine Biopharma position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.

The idea behind Sunshine Biopharma and Pacira BioSciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.